Medicinal cannabis for seniors: extra care, extra benefit

Older New Zealanders are an increasingly significant group of medicinal cannabis patients, often turning to it for chronic pain, sleep problems and the symptoms of long-term conditions. There are good reasons for the interest — but ageing also changes how the body responds to cannabinoids, and that calls for extra care. This guide is for seniors and the families supporting them.

Why caution matters more with age

Several age-related factors make careful prescribing especially important:

• Falls and dizziness. THC can cause light-headedness, a drop in blood pressure on standing, and unsteadiness. In an older, fall-prone person, that's a serious risk — a fall can be life-changing.
• More medicines, more interactions. Older patients often take several medications. CBD inhibits liver enzymes that process many common drugs (including warfarin), and THC adds to the sedation of sleeping tablets, opioids and alcohol. The more medicines on board, the more carefully interactions must be checked.
• Slower metabolism. Ageing organs can clear drugs more slowly, so effects may be stronger or last longer than expected.
• Heart and cognition. THC's effect on heart rate and blood pressure, and its potential to cloud concentration and memory, deserve extra attention in older patients.

None of this rules cannabis out — it simply means "start low, go slow" matters even more, and the lowest effective dose is the goal.

Where it may help

Among the conditions common in later life, the better-supported uses tend to involve THC-based products for chronic pain (though the demonstrated effect is generally modest) and, with more limited evidence, sleep. Palliative care is another setting where cannabis is sometimes used adjunctively to ease symptoms, though here too the evidence is low-quality and the approach is individualised. CBD-dominant products, being non-intoxicating, are often a sensible starting point for older patients where avoiding impairment and falls is a priority.

It's worth being realistic: cannabis is not a first-line treatment for any condition, and for several conditions of older age (such as Parkinson's motor symptoms or dementia agitation) the evidence is insufficient or weak.

Practical advice for seniors and families

• Bring a complete medication list to the consultation — every prescription, over-the-counter medicine and supplement.
• Start with a non-intoxicating option where appropriate, and titrate especially slowly.
• Take the first doses safely — seated, at home, with someone nearby.
• Watch for dizziness and falls in the early weeks; remove trip hazards and consider extra support at home.
• Keep the regular GP informed, since they hold the full medication picture.
• Store products safely, especially if grandchildren visit.
• Involve whānau. A support person at consultations and with dosing makes the whole process safer.

Cost considerations

Cost can weigh heavily on those living on a fixed income, and medicinal cannabis is generally not Pharmac-funded. Some clinics offer SuperGold or pensioner concessions on consultation fees, which is worth asking about. Finding the lowest effective dose also keeps product costs down.

Sleep, pain and the realities of ageing

Two of the most common reasons older people seek medicinal cannabis are poor sleep and persistent pain — and both deserve a realistic framing. For sleep, the evidence is limited and emerging, with any benefit driven mainly by THC-containing products; CBD-only products haven't shown a significant effect on sleep in the research. THC can also disrupt REM sleep and cause next-day grogginess, which in an older person feeds back into fall risk. For pain, the large evidence base shows only a small average benefit, and cannabis sits as a last-line add-on rather than a replacement for other approaches. Setting these expectations honestly helps older patients judge whether a trial is worthwhile for them.

It's also worth remembering that many conditions of later life — Parkinson's motor symptoms, dementia-related agitation — have insufficient or weak evidence for cannabis, and THC's effects on cognition, balance and blood pressure can be particularly risky in these groups. A cautious, well-monitored trial with clear goals is the right approach, and stopping if it isn't clearly helping is entirely reasonable.

Questions for the consultation

Older patients and their families might ask: Given my other medicines, are there interactions to worry about? Would a non-intoxicating product be safer for me? How might this affect my balance and fall risk? How will we know if it's working, and when would we stop? What's the lowest dose we can start with? These questions keep the focus on safety and realistic benefit.

The bottom line

For many older New Zealanders, medicinal cannabis offers genuine potential to ease pain and improve sleep and quality of life. But ageing raises the stakes on side effects, falls and interactions, so the medicine should be approached with extra caution: a non-intoxicating start where appropriate, very slow titration, a watchful eye on falls and drug interactions, and close involvement from both the GP and whānau. Done carefully, it can be a valuable addition to an older person's care.

Last reviewed 31 August 2026 — education, not medical advice. Sources: bpacnz; Journal of Pain and Symptom Management 2022 — palliative review00760-6/fulltext).